2024_PRETEST FARMAKOLOGI BLOK 1.M. CPO

2024_PRETEST FARMAKOLOGI BLOK 1.M. CPO

University

20 Qs

quiz-placeholder

Similar activities

Kuis CBC 2021

Kuis CBC 2021

University

15 Qs

Pendidikan Bahasa Indonesia

Pendidikan Bahasa Indonesia

University

20 Qs

Mengenal Virus Covid-19

Mengenal Virus Covid-19

4th Grade - University

20 Qs

SOAL WAWANCARA PAKET 2

SOAL WAWANCARA PAKET 2

University

20 Qs

Do you know Radio Untar?

Do you know Radio Untar?

University

15 Qs

POST TEST MBMT

POST TEST MBMT

University

20 Qs

Mrk - DaPembd

Mrk - DaPembd

University

15 Qs

Quiz Alkitab

Quiz Alkitab

KG - Professional Development

20 Qs

2024_PRETEST FARMAKOLOGI BLOK 1.M. CPO

2024_PRETEST FARMAKOLOGI BLOK 1.M. CPO

Assessment

Quiz

Other

University

Easy

Created by

muri Arisanti

Used 22+ times

FREE Resource

20 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Pemberian obat melalui oral merupakan satu-satunya cara untuk mencapai efek sistemik
BENAR
SALAH

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Obat yang diberikan secara sublingual harus melewati hepar sebelum mencapai sirkulasi sistemik.
BENAR
SALAH

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Efek lokal obat hanya dapat dicapai melalui pemberian topikal pada kulit.
BENAR
SALAH

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Injeksi intravena dilakukan untuk keadaan gawat darurat karena memungkinkan obat langsung masuk ke dalam aliran darah vena.
BENAR
SALAH

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Tablet salut enterik dirancang untuk pecah di dalam lambung.
BENAR
SALAH

6.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Pemberian obat perrectal dapat menghindari first pass metabolism di hepar.
BENAR
SALAH

7.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Semua jenis obat diabsorpsi dengan baik di lambung.
BENAR
SALAH

Create a free account and access millions of resources

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

By signing up, you agree to our Terms of Service & Privacy Policy

Already have an account?